Oncolytics Biotech Inc. (Nasdaq: ONCY) announced results examining percent overall tumour shrinkage data from its U.S. Phase 2 clinical trial ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE